ArticleJournal of Ayurveda and integrative medicine
Biochemical rationale for dietary management of COVID-19 patients: Indian traditional millets as a promising integrative nutritional strategy.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), imposes a significant metabolic and nutritional burden on the human host. Viral replication requires synthesis of structural proteins (S, E, M, and N), which in turn depends on an adequate supply of amino acids. While the human body can synthesize all nucleotides, it cannot synthesize eight essential amino acids (EAAs), which must be derived from dietary intake or through catabolism of endogenous protein stores such as skeletal muscle and albumin. Despite numerous dietary advisories for COVID-19 patients, including those from international agencies, none are grounded in a biochemical analysis of viral amino acid requirements.
objectivesThis study aimed to determine the amino acid distribution of SARS-CoV-2 structural proteins and to identify nutritionally optimal, economically accessible staple and widely consumed foods capable of counteracting the essential amino acid burden during COVID-19. MATERIALS AND
methodsIn this computational study, the amino acid profiling of SARS-CoV-2 structural proteins was performed using bioinformatics analysis of genomic sequences obtained from the GenBank database. The amino acid composition of commonly consumed foods was derived from the Indian Food Composition Tables (IFCT) 2017. Viral amino acid requirements were quantitatively compared with the amino acid profiles of cereals, millets, legumes, nuts, milk, and eggs to assess their suitability in meeting essential amino acid demands.
resultsSynthesis of SARS-CoV-2 structural proteins required all 20 amino acids. Essential amino acids constituted 42.8% of the total amino acid requirement, with branched-chain amino acids (valine, leucine, and isoleucine) accounting for approximately 23%. The nutritional load per virion ranged from 1.6% for methionine to 11.3% for leucine. Rice, wheat, maize, legumes, and even expensive nuts like almond, cashew nut, pistachio nuts and walnut were insufficient in meeting the most abundantly required EAAs. In contrast, millet-based diets, particularly combinations of pearl millet with sorghum or foxtail millet, showed superior amino acid complementarity. Cow milk closely matched overall EAA requirements, while foxtail millet supplemented with eggs provided an optimal mixed-diet option.
conclusionThis study provides a biochemical rationale for dietary management of COVID-19 and identifies Indian traditional millets as a nutritionally effective and integrative dietary strategy to mitigate essential amino acid burden during SARS-CoV-2 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.